Showing results (81-90 of 145) with videos related to
Sort By:
Pageof 15
Multiple Sclerosis and Related Disorders|March 5, 2026
Appendicitis and multiple sclerosis disease-modifying therapies: a disproportionality analysis of the FDA adverse event reporting systemAlexandra Balshi, Madelyn Esser, John P Dempsey, et al.Psychopharmacology|June 26, 2007
Appetitive nature of drug cues re-confirmed with physiological measures and the potential role of stage of changeJared P Dempsey, Lee M Cohen, Valerie L Hobson, et al.American Journal of Industrial Medicine|August 1, 1996
Injury and illness in the American workplace: a comparison of data sourcesP L Murphy, G S Sorock, T K Courtney, et al.Molecular and Cellular Probes|May 16, 2001
Detection of West Nile virus in mosquitoes by RT-PCRT L Hadfield, M Turell, M P Dempsey, et al.Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 22, 2024
The Effect of Preoperative Chlorhexidine Gluconate Cleanse on Lower Extremity Surgical Site Infections: A Retrospective Cohort StudyMichael P Dempsey, Alexandria M Riopelle, Margaret West, et al.The Journal of Chemical Physics|March 19, 2009
State-resolved distribution of OH X 2Pi products arising from electronic quenching of OH A 2Sigma+ by N2Logan P Dempsey, Timothy D Sechler, Craig Murray, et al.The American Journal on Addictions|November 27, 2008
The influence of monetary compensation on relapse among addicted participants: empirical vs. anecdotal evidenceJared P Dempsey, Sudie E Back, Angela E Waldrop, et al.Nature Immunology|January 9, 2025
Low-avidity T cells drive endogenous tumor immunity in mice and humansSummit Singhaviranon, Joseph P Dempsey, Adam T Hagymasi, et al.Journal of Bacteriology|August 4, 2006
Paired-end sequence mapping detects extensive genomic rearrangement and translocation during divergence of Francisella tularensis subsp. tularensis and Francisella tularensis subsp. holarctica populationsMichael P Dempsey, Joseph Nietfeldt, Jacques Ravel, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 26, 2025
Malignant melanoma and multiple sclerosis therapies: A disproportionality analysis of the FDA adverse event reporting systemAlexandra Balshi, John P Dempsey, Nova Manning, et al.Pageof 15